Tue, June 9, 2009
Mon, June 8, 2009
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009
Mon, June 1, 2009
Sat, May 30, 2009
Fri, May 29, 2009
Thu, May 28, 2009
Wed, May 27, 2009
Tue, May 26, 2009
Mon, May 25, 2009
Fri, May 22, 2009
Thu, May 21, 2009
Wed, May 20, 2009
Tue, May 19, 2009
Mon, May 18, 2009
Fri, May 15, 2009
Thu, May 14, 2009
Wed, May 13, 2009
Tue, May 12, 2009
Mon, May 11, 2009
Fri, May 8, 2009
Thu, May 7, 2009
Thu, April 16, 2009
Wed, April 15, 2009
Tue, April 14, 2009
Mon, April 13, 2009
Fri, April 10, 2009
Thu, April 9, 2009
Wed, April 8, 2009
Tue, April 7, 2009
Mon, April 6, 2009
Fri, April 3, 2009
Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Sun, March 15, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009
Fri, March 6, 2009

The Medicines Company: The Medicines Company to Announce First Quarter 2009 Financial Results on Wednesday, April 29, 2009


//health-fitness.news-articles.net/content/2009/ .. inancial-results-on-wednesday-april-29-2009.html
Published in Health and Fitness on , Last Modified on 2009-04-15 14:12:56 by Market Wire   Print publication without navigation


PARSIPPANY, NJ--(Marketwire - April 15, 2009) - The Medicines Company (NASDAQ: [ MDCO ]) has scheduled its quarterly conference call for Wednesday, April 29, 2009 at 8:30 a.m. Eastern Time to discuss first quarter 2009 financial results and operational developments.

The conference call will be available via phone and webcast. The dial in information is listed below:

 Domestic Dial In: 800-706-7745 International Dial In: 617-614-3472 Passcode for both dial in numbers: 34239136 

Replay is available from 11:30 a.m. Eastern Time following the conference call through May 13, 2009. To hear a replay of the call, dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 33236910.

This call is being webcast and can be accessed at The Medicines Company website at [ www.themedicinescompany.com ].

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU2010, in early-stage development. Through the acquisition of Targanta Therapeutics, The Medicines Company's pipeline also includes oritavancin, a semi-synthetic lipoglycopeptide antibiotic currently awaiting EU regulatory approval. The Medicines Company's website is [ www.themedicinescompany.com ].


Publication Contributing Sources

Similar Health and Fitness Publications